Fowl adenovirus vaccine
AssigneeVeterinarmedizinische Universitat Wien
InventorsMichael Hess, Anna Schachner, Ana Marek, Barbara Jaskulska
Life of this patent
Estimating the term…
Abstract
Disclosed is a vaccine comprising a fiber protein, selected from fiber-2 protein of Fowl Adenovirus C (FAdV-C), fiber-2 protein of Fowl Adenovirus A (FAdV-A), fiber protein of Fowl Adenovirus B, D and E (FAdV-B, FAdV-D and FAdV-E), or an immunogenic fragment thereof for use in preventing hepatitis-hydropericardium Syndrome (HHS) or inclusion body hepatitis (IBH) or Gizzard Erosion (GE) in birds, preferably in poultry, especially in broilers.
Claims23
A vaccine comprising a fiber protein further defined as:
- fiber-2 protein of Fowl Adenovirus C (FAdV-C);
- fiber-2 protein of Fowl Adenovirus A (FAdV-A);
- or
- fiber protein of Fowl Adenovirus B, D, or E (FAdV-B, FAdV-D, or FAdV-E),
- wherein the vaccine is further defined as a subunit vaccine, and
- wherein the vaccine further comprises an immuno-effective amount of an adjuvant.
A vaccine suitable for vaccinating against a FAdV infection in birds, comprising a fiber protein further defined as:
- fiber-2 protein of FAdV-C;
- or
- fiber protein of FAdV-D or FAdV-E,
- wherein the vaccine is further defined as a subunit vaccine, and wherein the vaccine further comprises an immuno-effective amount of an adjuvant.
Dependencies are inferred from the claim text.